# Top 50 Health Care Startup Investors in Denmark in May 2026

## Novo Holdings
- Type: VC Fund
- Location: Hellerup, Hovedstaden, Denmark
- Relevant deals: 21
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Medical

Novo Holdings is a world-leading life science investor with a focus on creating long-term value.

## Vaekstfonden
- Type: VC Fund
- Location: Hellerup, Hovedstaden, Denmark
- Relevant deals: 17
- Stages: Seed, Pre-Seed
- Focus: Software, Information Technology, SaaS

Vaekstfonden – The Danish Growth Fund – is the Danish state's investment fund. We strive to improve access to risk capital to enable Danish businesses to innovate, and to generate growth and new jobs. In close collaboration with banks and domestic and international private investors, we finance companies from all sectors nation-wide. We canaccompany you for the entire journey – from your company’s infancy through growth phases to expansion abroad and even to an initial public offering.

## BioInnovation Institute
- Type: VC Fund
- Location: Copenhagen, Hovedstaden, Denmark
- Relevant deals: 15
- Stages: Convertible Note, Debt Financing, Pre-Seed
- Focus: Biotechnology, Medical, Health Care

BioInnovation Institute is a biotechnology startup that offers entrepreneurs and researchers in life science. Early-stage life science start-ups are supported with up to 10 million DKK in funding, business acceleration, network, labs, and office space. It helps to early-stage start-ups within human health and planetary health. The startup'smission is to use its knowledge, network, funding, and infrastructure to incubate world-class life science and catalyze the commercialization of new solutions through start-ups.BioInnovation Institute was founded in 2018 and is based in Denmark.

## PreSeed Ventures
- Type: VC Fund
- Location: Lyngby, Hovedstaden, Denmark
- Relevant deals: 14
- Stages: Seed, Pre-Seed
- Focus: Software, Information Technology, SaaS

PreSeed Ventures is the biggest and most succesful early stage investor in Denmark. For more than 20 years, PreSeed Ventures have assisted and financed talented entrepreneurs with early-stage investments, and we hold more than 70 companies in our portfolio.

## Seed Capital
- Type: VC Fund
- Location: Copenhagen, Hovedstaden, Denmark
- Relevant deals: 13
- Stages: Seed, Series A
- Focus: Software, Health Care, SaaS

Seed Capital invests in Danish tech businesses with global ambitions. We are focused on "late seed"-stage companies, typically investing 1-3 MEUR in rounds of 1-6 MEUR. Proud backers of Trustpilot, Vivino, Lunar, Templafy, Dixa, Forecast, and many other great companies.

## Sunstone Life Science Ventures
- Type: VC Fund
- Location: Copenhagen, Hovedstaden, Denmark
- Relevant deals: 10
- Stages: Series B, Series A
- Focus: Biotechnology, Health Care, Medical

Sunstone Life Science Ventures is an independent European venture capital investment firm. We enable and empower life science therapeutics innovations.

## People Ventures
- Type: VC Fund
- Location: Taastrup, Hovedstaden, Denmark
- Relevant deals: 6
- Stages: Seed, Pre-Seed, Series A
- Focus: Health Care, Internet of Things, Software

People Ventures are your dreamcast team of co-founders, investors, executives, engineers, academics and industry experts.
Together with talented entrepreneurs — We shape fantastic businesses through operational and commercial execution.

## Gilde Healthcare
- Type: VC Fund
- Location: Utrecht, Utrecht, The Netherlands
- Relevant deals: 4
- Stages: Series C, Series B, Series A
- Focus: Biotechnology, Health Care, Medical

Gilde Healthcare is a specialized European healthcare investor managing two business lines: a lower mid-market buy-out fund and a venture & growth capital fund. It has over €800 million ($900 million) under management and is actively looking to lead new investments in digital health, diagnostics, medical devices, therapeutics and healthcareservices. Gilde successfully builds healthcare businesses across Europe and US, investing up to €35 million in a single portfolio company.

## VF Venture
- Type: VC Fund
- Relevant deals: 4
- Stages: Seed, Series A
- Focus: Software, Biotechnology, SaaS

Vaekstfonden makes equity investments in Danish companies with a track record as well as in young entrepreneurial, innovative enterprises with an ambition for global growth.

## West Hill Capital
- Type: VC Fund
- Location: London, England, United Kingdom
- Relevant deals: 4
- Stages: Seed, Series A
- Focus: Information Technology, Software, Health Care

West Hill Corporate Finance is a leading private equity venture capital firm providing EIS qualifying high-growth investments to private individuals.

## Crista Galli Ventures
- Type: VC Fund
- Location: Copenhagen, Hovedstaden, Denmark
- Relevant deals: 3
- Stages: Seed, Pre-Seed, Series A
- Focus: Health Care, Wellness, Medical

Crista Galli Ventures invests in ambitious European healthtech companies at Seed and Series A. Our deep medical expertise, powerful network and agile approach enable founders to build important, world-class healthcare businesses.

## RA Capital Management
- Type: VC Fund
- Location: Boston, Massachusetts, United States
- Relevant deals: 3
- Stages: Series B, Series A, Series C
- Focus: Biotechnology, Health Care, Therapeutics

RA Capital Management is an investment advisor based in Boston specializing in the life-sciences and drug development sectors. The company's team has been investing since 2002 and is comprised of professionals with training in biology, chemistry, and medicine and also has industry and business development experience at the executive and boardlevels. The company invests in companies with promising technologies and products.

## byFounders
- Type: VC Fund
- Location: Copenhagen, Hovedstaden, Denmark
- Relevant deals: 3
- Stages: Seed, Series A, Pre-Seed
- Focus: Software, Artificial Intelligence, Mobile Apps

byFounders is the community-powered early-stage venture fund investing in globally ambitious teams connected to the Nordic and Baltic countries. With its unique Collective of founders and operators, byFounders offers its portfolio operational expertise and a global network. Believing in the power of tech to shape our future, byFounders takes an impact-aware approach to investing and working with the broader startup ecosystem.

## Oskare Capital
- Type: VC Fund
- Location: Paris, Ile-de-France, France
- Relevant deals: 3
- Stages: Seed, Pre-Seed, Series A
- Focus: Health Care, Biotechnology, Medical

Oskare Capital is a venture capital firm.

## Innovation Fund Denmark
- Type: VC Fund
- Location: Copenhagen, Hovedstaden, Denmark
- Relevant deals: 3
- Stages: Grant, Pre-Seed, Seed
- Focus: Software, SaaS, Information Technology

Innovation Fund Denmark invests in the development of new knowledge and technology creating growth and employment in Denmark. The Fund focuses on societal challenges, strengthens research, and increases innovation commitment within private companies.The Fund provides risk capital that enables cutting-edge initiatives to achieve resultssubstantially impacting the Danish society. Innovation Fund Denmark is also responsible for the future societal partnerships, where companies, universities, and public authorities will work together on challenges facing the society today.

## EIR Ventures
- Type: VC Fund
- Location: Stockholm, Stockholms Lan, Sweden
- Relevant deals: 3
- Stages: Series A, Seed
- Focus: Biotechnology, Health Care, Therapeutics

EIR Ventures is a new Life Science Venture Group in the Nordics.

## HealthCap
- Type: VC Fund
- Location: Stockholm, Stockholms Lan, Sweden
- Relevant deals: 3
- Stages: Series B, Series A
- Focus: Biotechnology, Health Care, Medical

HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.

## Sofinnova Partners
- Type: VC Fund
- Location: Paris, Ile-de-France, France
- Relevant deals: 3
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Medical

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

## Sweet Capital
- Type: VC Fund
- Location: Stockholm, Stockholms Lan, Sweden
- Relevant deals: 3
- Stages: Seed, Series A
- Focus: Apps, Software, Mobile

Sweet is the King.com (Candy Crush) founders' investment fund. We are passionate about funding the next generation of entrepreneurs focused on creating a positive impact through consumer technology.

## CAPNOVA
- Type: VC Fund
- Location: Aarhus, Midtjylland, Denmark
- Relevant deals: 2
- Stages: Seed, Pre-Seed
- Focus: Software, Information Technology, Internet

They are an investment and development company providing capital, solid business experience and a strong network in order to turn innovative ideas into successful businesses. They cover all of Denmark from their offices in Aarhus, Roskilde, Copenhagen, Viborg and Kalundborg.

## 14W
- Type: VC Fund
- Location: New York, New York, United States
- Relevant deals: 2
- Stages: Seed, Series A, Series B
- Focus: E-Commerce, Fashion, Marketplace

14W is a Venture Capital firm based in New York, focusing on the intersection of technology and consumer behaviour.

## M Ventures
- Type: VC Fund
- Location: Amsterdam, Noord-Holland, The Netherlands
- Relevant deals: 2
- Stages: Series A, Series B, Seed
- Focus: Biotechnology, Health Care, Therapeutics

Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.

## Lundbeckfonden Ventures
- Type: VC Fund
- Location: Copenhagen, Hovedstaden, Denmark
- Relevant deals: 2
- Stages: Series B, Series A, Series C
- Focus: Biotechnology, Health Care, Therapeutics

Lundbeckfond Ventures is an evergreen life science venture fund established in the autumn of 2009 and wholly owned by the Lundbeck Foundation. The structure as an evergreen fund allows flexibility in the investment approach and the possibility, when appropriate, to take a long-term perspective in the investments. On an annual basis, LundbeckfondVentures invests up to € 50 million.Lundbeckfond Ventures is a financially driven venture fund generating returns to support the group's activities and operating independently from the Lundbeck Foundation’s controlling ownerships in H. Lundbeck A/S, ALK-Abelló and Falck.

## Christian Dörffer
- Type: Angel
- Location: Lisbon, Lisboa, Portugal
- Relevant deals: 2
- Stages: Seed, Series A
- Focus: Apps, Software, Mobile

Christian Dörffer is the Investor at Metafy, CEO and Co-Founder at Sweet Capital, and Founder and Chairman at Midnight Runners. He is a former Founder and Partner at BAMCAP. He attended Copenhagen Business School.

## Novo Ventures
- Type: VC Fund
- Location: Bagsværd, Hovedstaden, Denmark
- Relevant deals: 2
- Stages: Series B, Series A, Series C
- Focus: Biotechnology, Health Care, Medical

Novo A/S is a Danish private limited liability company wholly owned by the Novo Nordisk Foundation, and the holding company of the Novo Group and as such the majority shareholder in the publicly listed companies Novo Nordisk A/S and Novozymes A/S.Novo A/S was established in 1999 prior to the demerger of Novo NordiskA/S, where Novozymes A/S was established as a stand-alone publicly listed company. Novo's purpose and objectives are to manage the Foundation's financial assets and to ensure the Foundation sufficient dividends to cover its grant obligations for medical and scientific research etc. in Scandinavia.Novo A/S attains these objectives through:compliance with the rules and principles which are set out in the Articles of Association of the Novo Nordisk Foundation regarding exercise of the voting rights of A and B shares in Novo Nordisk A/S and Novozymes A/S, respectively, assurance that all companies in which the company has a material influence actively contribute to the development of the Novo Group and operate their business in accordance with the visions and values of the Novo Group, maintenance of a material influence on Novo Nordisk A/S and Novozymes A/S, and investment and financing business including placing of capital in companies and real property domestically and abroad.Novo’s overall investment strategy is thus to maintain ownership of Novo Nordisk’ and Novozymes’ shares at a level just above 25% and to invest dividends from these companies and other income in the life science area as well as in a broad portfolio of financial assets.Novo A/S has since 1999 established itself as an international venture capital partner in the life science area and has invested in over 50 companies in Denmark, Europe and North America. Through its financial investment activities Novo A/S seeks to spread the company’s total financial risk and at the same time to ensure a high return taking into consideration the chosen risk profile. In 2007 Novo A/S together with the Novo Nordisk Foundation established ‘Novo Seeds’. The new program (split into two sub-programs) is aimed at supporting early stage applied research in the life science area in Scandinavia. At the beginning of 2009 Novo A/S launched a new initiative, investing 'growth equity' into promising later stage/commercial stage life science companies. Novo A/S represents the interests of the Novo Nordisk Foundation through participation on the boards of the companies in the Novo Group.The companies in the Novo Group are members of a 'family of companies', independently managed, but sharing a set of common values as set out in the 'Charter for Companies in the Novo Group'. In the Charter these core values, commitments and management principles that companies in the Novo Group should live up to are described.

## Balderton Capital
- Type: VC Fund
- Location: London, England, United Kingdom
- Relevant deals: 2
- Stages: Series A, Series B, Series C
- Focus: Software, FinTech, Financial Services

In the two decades since our founding, we have worked with hundreds of extraordinary European founders, and have raised eight funds totalling more than $3bn.

## Johnson & Johnson Development Corporation
- Type: VC Fund
- Location: New Brunswick, New Jersey, United States
- Relevant deals: 2
- Stages: Series C, Series B, Series A
- Focus: Health Care, Biotechnology, Medical

JJDC, Inc. is the strategic venture capital arm of Johnson & Johnson Innovation. Learn more about our equity investment strategy.

## Alexander Rindom-Andersen
- Type: Angel
- Relevant deals: 2
- Stages: Pre-Seed
- Focus: Mobile, Software, Freelance

Alexander Rindom-Andersen is the Co-founder & CEO @ Naetion

## VentureFriends
- Type: VC Fund
- Location: Athens, Attiki, Greece
- Relevant deals: 2
- Stages: Seed, Series A
- Focus: FinTech, Software, E-Commerce

We are an early stage investor investing in Seed and Series A startups.

## Aescap Venture
- Type: VC Fund
- Location: Amsterdam, Noord-Holland, The Netherlands
- Relevant deals: 2
- Stages: Series A, Series B
- Focus: Biotechnology, Pharmaceutical, Chemical

The Aescap funds invest in highly innovative publicly traded biotech/life sciences companies. We're able to select the promising companies

## Inventure
- Type: VC Fund
- Location: Helsinki, Southern Finland, Finland
- Relevant deals: 2
- Stages: Seed, Series A
- Focus: Software, Information Technology, Health Care

Since 2005, Inventure has backed over 90 companies including Wolt, Swappie, Jobbatical, aiMotive, and more.

## Ysios Capital
- Type: VC Fund
- Location: San Sebastian, Pais Vasco, Spain
- Relevant deals: 2
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Medical

Leading #lifesciences #venturecapital firm financing highly #innovative #biotechnology companies #worlwide.

## Stine Molgaard Sorensen
- Type: Angel
- Location: Copenhagen, Hovedstaden, Denmark
- Relevant deals: 2
- Stages: Pre-Seed
- Focus: Robotics, Software, Health Care

Stine Molgaard Sorensen is the Co-founder and COO of Radiobotics.

## CBC Investment Group
- Type: VC Fund
- Location: Gothenburg, Vastra Gotaland, Sweden
- Relevant deals: 2
- Stages: Seed, Series B
- Focus: Biotechnology, Software, SaaS

CBC Investment Group started in 2009 in the midst of the financial crisis. The banks were on their knees, start-ups of small and medium-sized companies - all of a sudden they saw their credit and credit promises turned into demands for quick repayment and empty words. Serious talented entrepreneurs' ideas and companies risked going completelyunnecessary. In response to this crisis, they started the CBC Investment Group.

## Thomas Ryge Mikkelsen
- Type: Angel
- Location: Copenhagen, Hovedstaden, Denmark
- Relevant deals: 2
- Stages: Seed, Series A
- Focus: E-Commerce, Beauty, Fashion

Thomas Ryge Mikkelsen is an Investor and Chairman at Nøie.

## Karolinska
- Type: VC Fund
- Location: Solna, Stockholms Lan, Sweden
- Relevant deals: 2
- Stages: Seed, Series A
- Focus: Biotechnology, Health Care, Pharmaceutical

Karolinska Development aims to create value for patients, researchers, investors and society by developing innovations from world class science into products that can be sold or out-licensed with high returns. The business model is to: SELECT the most commercially attractive medical innovations; DEVELOP innovations to the stage where the greatestreturn on investment can be achieved; and COMMERCIALIZE the innovations through the sale of companies or out-licensing of products.Karolinska Development has developed a well-structured selection process to identify the most commercially attractive medical innovations screened by KIAB. Pharmaceutical development is a high-risk enterprise. In most cases, development projects fail because of side effects or insufficient efficacy. Successful selection of innovations is fundamental to Karolinska Development’s business model, which makes the inflow of new projects crucial. One key to success lies in selecting those innovations that can be developed from scientific findings to products and have significant commercial potential. To date, over 1,300 projects have been screened by KIAB.The portfolio companies are often founded together with the innovators and are initially operated as virtual companies with few or no employees. During the first six to twelve months, the companies normally have minimal fixed costs and technological development is outsourced.The innovator, who is often employed at an academic institution, normally participates as a board member and scientific advisor. The CEO of a portfolio company cooperates closely with a representative of Karolinska Development, who in most cases is also a board member of the company. The companies are capitalized to reach their next milestone, usually within a period of six to eighteen months. Development projects are continuously monitored, and those that do not meet their stipulated targets are discontinued. In the first three to four years, a portfolio company’s operating expenses are often limited to a few million Swedish kronor per year, which cover the cost of external studies and the salary of the staff. In subsequent years, Karolinska Development and other investors play an important role recruiting key expertise to the companiesKarolinska Development intends to realize value by exiting portfolio companies or through out-licensing of projects. Such transactions (especially out-licensing) are often structured as single upfront payments followed by payments based on predetermined milestones and royalties on sales. Although Karolinska Development has a flexible exit strategy, pharmaceutical products are, for two reasons, preferably exited at Phase II. First a successful Phase II study indicates that the pharmaceutical has an effect on patients, which is an important value-enhancing factor when negotiating out-licensing or sales. Secondly, finalizing product development and undertaking Phase III clinical trials frequently requires very large patient populations. In many cases this requires much greater resources than those available at Karolinska Development but these can be found in established pharmaceutical companies. Several licensing deals were closed in 2011 involving projects with a similar focus and development phase to Karolinska Development's projects.

## Bruce Linton
- Type: Angel
- Location: Ottawa, Ontario, Canada
- Relevant deals: 2
- Stages: Seed, Post-IPO Equity, Pre-Seed
- Focus: Health Care, Cannabis, Biotechnology

Mr. Linton is the founder of Canopy Growth Corporation (CGC) and co-founder of Tweed Marijuana Inc.Bruce’s primary focus has been to position cannabis brands in a competitive market and to raise the capital necessary to fund such operations. Bruce’s experience as a founder, CEO, and Board member across a wide variety of enterprises has influencedthe positive start of Canopy Growth, which to date has enjoyed market support for capital raises of over $150 million and the distinction of being the first company in the industry to be offered debt instruments by a federal lender. Bruce has led three M&A transactions valued over $500 million total since founding CGC. In addition to his leadership responsibility at Canopy Growth, Bruce is the CEO of communications company Martello Technologies. After beginning his career at Newbridge Networks Corporation, he has since held positions that include General Manager and Re-Founder of Computerland.ca, President and Co-Founder of webHancer Corp, and part of the establishing team at CrossKeys Systems Corporation. He was also part of the leadership team for the NASDAQ/TSX initial public offering at CrossKeys. Bruce has been responsible for the acquisition and/or disposition of over $600 million in business assets, and has established regular engagement with the World Bank and Asia Development Bank while focused on markets in India, Philippines, China, Peru, Colombia, Ecuador, Azerbaijan and Uzbekistan. He is the past Chairman of the Ottawa Community Loan Foundation, past Board Member and Treasurer of Canada World Youth past Board of Governor for Carleton University, past President of the Nepean Skating Club and past President of the Carleton University Students Association.

## Crowberry Capital
- Type: VC Fund
- Location: Reykjavík, Gullbringusysla, Iceland
- Relevant deals: 2
- Stages: Seed, Pre-Seed, Series A
- Focus: Software, Gaming, Information Technology

Crowberry Capital invests at seed and early stage in emerging technology ventures in the Nordics. Our mission is to back people that are good for companies and build companies that are good for people. We have a strong follow-through philosophy and commit to putting your company first.

## Industrifonden
- Type: VC Fund
- Location: Stockholm, Stockholms Lan, Sweden
- Relevant deals: 2
- Stages: Series A, Seed
- Focus: Software, Biotechnology, Information Technology

Industrifonden is a Nordic evergreen venture capital firm with a fund size of $600m, that focuses on early-stage technology and life science companies with international potential. The company works long term with the entrepreneurs we invest in, and have a strong track record of building game changing companies. Industrifonden-backed companiesinclude tech companies Qlik, Arcam, Soundtrack Your Brand, Fishbrain, and life science companies CellaVision, Oncopeptides and AMRA.

## Wellington Partners
- Type: VC Fund
- Location: Munich, Bayern, Germany
- Relevant deals: 2
- Stages: Series A, Series B
- Focus: Health Care, Biotechnology, Medical

Wellington Partners is a venture capital firm that invests in technology and life sciences companies, focusing on Digital Media, Software, Electronics & Photonics, Resource Efficiency, and Biotech/Life Sciences. It is committed to providing outstanding entrepreneurs with the necessary resources to fund their strategies. We typically leadfinancing rounds ranging from € 0.5 million to € 20 million. Depending on the maturity of the company, its own commitment can go as high as € 15 million.Wellington was established in 1998 and has offices in Munich, London, and Zurich.

## Investo Capital
- Type: VC Fund
- Location: Aalborg, Nordjylland, Denmark
- Relevant deals: 2
- Stages: Seed
- Focus: Health Diagnostics, Computer, Software

Investo Capital is a Danish venture capital firm based in Aalborg. They invest in carefully selected Danish early-growth companies within tech business areas in the broad sense. The target group is innovative companies with proof of business, strategic thinking, and strong growth prospects in Denmark. Strategic corporate concepts and competentmanagement are essential features. The investment focus is Technology, IT, SAAS- and med-tech.

## DKA Capital
- Type: VC Fund
- Location: Copenhagen, Hovedstaden, Denmark
- Relevant deals: 1
- Stages: Series B
- Focus: Software, Biopharma, CleanTech

DKA Capital (formerly Dansk Kapitalanlæg) is a well-established Danish PE fund investing in and developing knowledge-intensive growth companies with a global potential with the aim of creating long term sustainable value.Since DKA Capital was founded in 1984, we have completed 180 investments and 175 exits of which 21 were in the form ofIPO's (Initial Public Offerings). This makes us one of the largest and most experienced investors in Denmark.The specialisation process in DKA Capital was initiated in 2006 and in 2011 the management of DKA Capital together Norwegian Argentum acquired 75% of the fund DKA II.DKA Capital has through DKA II 5 companies in its portfolio. DKA II is owned by the management of DKA Capital, Argentum, Nordea Liv & Pension and Danica Pension. We believe in direct and constructive communication leaving no doubt to what DKA Capital stands for or what we would like to achieve during our period of ownership. Together with the companies we execute professionally and create sense-of-urgency. DKA Capital's aim is to be strategic and intelligent change of ownership. And we want to maintain our position as one of the most credible partners for knowledge-intensive growth companies.We invest in knowledge intensive companies with international growth opportunities. During the recent years we have marked ourselves as one of Denmark's leading funds within this field.

## Index Ventures
- Type: VC Fund
- Location: San Francisco, California, United States
- Relevant deals: 1
- Stages: Series A, Series B, Seed
- Focus: Software, E-Commerce, Internet

Index Ventures is an international venture capital firm with dual headquarters in San Francisco and London, investing in technology-enabled companies with a focus on e-commerce, fintech, mobility, gaming, infrastructure/AI, and security.

## The Market Development Fund
- Type: VC Fund
- Relevant deals: 1
- Stages: Seed
- Focus: Software, Health Care

The Market Development Fund helps enterprises bring their new products to the market faster.

## BII
- Type: VC Fund
- Location: Kfar Saba, HaMerkaz, Israel
- Relevant deals: 1
- Stages: Seed
- Focus: Wellness, Health Care

BII provides a system for booking hotels small and medium businesses and non-corporate companies. It offers an online hotel booking platform connected to over 50 global hotel suppliers and integrated into HOTELMIZE smart optimization engine and price predictive algorithms constantly to pull, track, and analyze the details of reservationsautomatically - utilizing their technological capabilities.

## North-East Healthcare Investment
- Type: VC Fund
- Location: Root, Luzern, Switzerland
- Relevant deals: 1
- Stages: Series A
- Focus: Therapeutics, Biotechnology, Medical Device

North-East is an ambitious, global family office helping our families live with wealth in a meaningful way from our offices in Denmark and Singapore.

## Teknoinvest
- Type: VC Fund
- Location: Oslo, Oslo, Norway
- Relevant deals: 1
- Stages: Series B, Series A
- Focus: Health Care, Biotechnology, Medical

Teknoinvest is a premier Scandinavian venture capital company. They invest in areas of emerging technologies within the ITC and Life Sciences sectors. Their main geographical scope is Scandinavia and the USA. Teknoinvest was established as the first venture capital investment company. Teknoinvest is one of the most successful VC´s in Scandinaviaaccording to track record of value created for their investors.

## EQT life science
- Type: VC Fund
- Location: Amsterdam, Noord-Holland, The Netherlands
- Relevant deals: 1
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Therapeutics

EQT life science develops innovative medicines, devices, and tools to address the single important thing that matters to the preservation of health. The organization believes that such opportunities add value to all stakeholders.

## Wellcome Trust
- Type: VC Fund
- Location: London, England, United Kingdom
- Relevant deals: 1
- Stages: Grant, Series C
- Focus: Biotechnology, Health Care, Pharmaceutical

Wellcome Trust is a medical research charity that funds research that aims to protect and improving human and animal health. It focuses on the fields of public engagement, investments, innovation, humanities, and social science.
It was founded in 1936 and headquartered in London, England.

## Alta Partners
- Type: VC Fund
- Location: San Francisco, California, United States
- Relevant deals: 1
- Stages: Series B, Series C, Series A
- Focus: Biotechnology, Health Care, Medical

Alta Partners is a leading healthcare and life sciences venture capital firm, helping entrepreneurs build high-impact companies since 1996.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co